GlassScriptPhysician profile
David D Duong
NPI 1740945583
$1,263.32
in general payments reported to CMS, 2019-2025
19 companies · $324 in 2025
The $324 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.34 · 2022: $280 · 2023: $34.64 · 2024: $608 · 2025: $324.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $967.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $966.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $421.31 | 2022-2025 | Relistor |
| Collegium Pharmaceutical, INC. | $231.60 | 2024-2025 | Belbuca, Xtampza |
| Abbvie INC. | $185.29 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $73.75 | 2021-2022 | |
| Atricure, INC. | $53.77 | 2023-2025 | Atriclip Laa Exclusion System |
| Averitas Pharma INC. | $38.08 | 2024-2025 | Qutenza |
| Lilly USA, LLC | $29.22 | 2022 | |
| Xeris Pharmaceuticals, INC. | $28.15 | 2022 | |
| Abbott Laboratories | $27.70 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.00 | 2022 | |
| Novo Nordisk INC | $19.76 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.86 | 2022 | |
| Ethicon US, LLC | $17.81 | 2025 | Vistaseal |
| Biohaven Pharmaceutical Holding Company LTD. | $17.75 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $17.71 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $17.69 | 2024 | Tirosint, Licart |
| Biotronik Nro, INC. | $15.67 | 2025 | Prospera |
| Nestle Healthcare Nutrition INC. | $13.67 | 2022 | |
| Janssen Pharmaceuticals, INC | $13.53 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Duong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.